POLYTECH Health & Aesthetics Expands Presence in Poland with New Subsidiary

POLYTECH Health & Aesthetics Expands into Poland

POLYTECH Health & Aesthetics, renowned for its innovative breast implant solutions, has taken a significant step in its European expansion by establishing a wholly owned subsidiary in Poland. This strategic move positions POLYTECH as the lone breast implant provider operating directly within the Polish market, allowing the company to enhance its service offerings and educational efforts aimed at local surgeons and patients.

The company's new subsidiary will enable Polish surgeons to access POLYTECH's unique portfolio of breast implants, which includes the B-Lite® series, known for being the world's first lightweight breast implants. Alongside B-Lite®, practitioners will also have access to the highly esteemed MESMO® and Microthane® implants, both recognized for their safety and quality worldwide.

A Commitment to the Polish Market

As the CEO of POLYTECH Health & Aesthetics, Prof. Dr. Karsten Hemmrich emphasized the economic potential of Poland’s burgeoning breast aesthetic market. He stated, "Poland is one of Europe’s most dynamic and growing markets for breast aesthetics and reconstruction. By establishing a direct presence, we are ensuring surgeons receive superior support and education while providing patients with greater access to our innovative solutions. We believe Polish women will significantly benefit from our unique implants, designed to deliver outstanding results and long-term confidence."

To spearhead this endeavor in Poland, POLYTECH has appointed Anna Siarkiewicz-Wittliff as the Country Manager. Siarkiewicz-Wittliff, who previously worked with Mentor, the current market leader in Poland, brings with her years of experience in breast aesthetics and a broad professional network. She expressed her enthusiasm about joining POLYTECH, stating, "I am very excited to bring POLYTECH’s unmatched portfolio to surgeons and patients in Poland. Together with my team, I look forward to ensuring that Polish women have access to the highest quality implants and the very best support in their personal journey."

Setting New Standards in Aesthetics

POLYTECH's entry into Poland is not just a corporate maneuver; it signifies a milestone in the company's mission to redefine global standards in breast aesthetics and reconstruction through a commitment to innovation, education, and patient-centered care. Moreover, with over 35 years in the industry, POLYTECH combines pioneering innovation with precision craftsmanship to guarantee top-quality products.

The B-Lite® implant represents a breakthrough offering that not only addresses the aesthetic needs but also enhances comfort for patients. Its introduction in Poland, alongside the Microthane® and MESMO® implants, provides a more comprehensive aesthetic solution that aligns with the evolving preferences of patients seeking both safety and natural aesthetic outcomes.

A Legacy of Quality and Satisfaction

POLYTECH has made significant investments in education through its POLYTECHconnect Academy, ensuring that both surgeons and patients are well-informed of the latest developments in breast aesthetics. With an industry-leading social media presence focused on these topics, the company continuously engages with its audience to maintain relevance and educate about new technologies and products.

The introduction of Lipografter® technology as part of POLYTECH's offerings extends its commitment to providing a diverse range of body contouring solutions, responsive to patient needs and trends. This technology integration highlights POLYTECH's dedication to not only improving patient outcomes but also elevating overall satisfaction.

In summary, POLYTECH Health & Aesthetics’ recent expansion into Poland reflects a bold commitment to service excellence while reaffirming its status as a leader in breast aesthetics and reconstruction. With direct operations in the region, it aims to provide unparalleled support to surgeons and their patients, ultimately contributing to improved health and aesthetic results in the community. As the company moves forward, it will undoubtedly set new benchmarks in the realm of aesthetic medical solutions across Europe and beyond.